New START for Kumar Muthalagappan

Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally

1

Kumar Muthalagappan has begun an advisory role with the oncology research organization START to aid its global expansion.
2

START aims to accelerate anti-cancer drug development to improve patient survival rates and quality of life.
3

Muthalagappan previously served as Strategic Advisor for CRIO, focusing on patient data collection for clinical trials.
4

He significantly grew MeDiNova from £500,000 to £40 million and expanded its operations to 106 sites across eight countries.
5

Muthalagappan founded Oncacare to connect patients, oncologists, and pharmaceutical organizations in global oncology.